Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

<p>Abstract</p> <p>Background</p> <p>Combination antiretroviral (AR) therapy continues to be the mainstay for HIV treatment. However, antiretroviral drug nonadherence can lead to the development of resistance and treatment failure. We have designed nanoparticles (NP) th...

Full description

Bibliographic Details
Main Authors: Sharma Akhilesh, Shibata Annemarie, Christensen Keith, Belgum Todd, Destache Christopher J, Dash Alekha
Format: Article
Language:English
Published: BMC 2009-12-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/9/198

Similar Items

Similar Items